Advanced glycation and lipoxidation end products: Reactive carbonyl compounds-related uraemic toxicity

Nephrology Dialysis Transplantation

Volumn 16, Issue SUPPL. 4, 2001, Pages 8-11

  Miyata, Toshio ^a   Saito, Akira ^a   Kurokawa, Kiyoshi ^a   Van Ypersele De Strihou, Charles ^b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2 ISOPROPYLIDENEHYDRAZONO 4 OXO 5 THIAZOLIDINYLACETANILIDE; 2 ISOPROPYLIDENEHYDRAZONO 4 OXO THIAZOLIDIN 5 YLACETANILIDE; ACETANILIDE DERIVATIVE; ACETYLCYSTEINE; ALDOSE REDUCTASE INHIBITOR; ALPHA TOCOPHEROL; AMINOGUANIDINE; CARBONYL DERIVATIVE; CYSTEINE; GLUTATHIONE; UNCLASSIFIED DRUG; UREMIC TOXIN;

AMYLOIDOSIS; ARTICLE; BIOCHEMISTRY; BLOOD LEVEL; HUMAN; INBORN ERROR OF METABOLISM; LIPID OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; TOXICITY; UREMIA;

EID: 0034948769     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.suppl_4.8     Document Type: Article

References (34)

1. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
2. Accumulation of Maillard reaction products in skin collagen in diabetes and aging
3. Pentosidine formation in skin correlates with severity of complication in individuals with long standing IDDM
4. Plasma level of pentosidine, an advanced glycation end product, in diabetic patients
5. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in the pathophysiology of pentosidine
6. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: Is there oxidative stress in uremia
7. Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: Evidence for increased oxidative stress in uremia
8. Carbonyl stress in uremia: Accumulation of carbonyls accelerate the formation of pentosidine, an advanced glycation end product
9. Elevated serum levels of 3 deoxyglucosone, a potent protein-cross-linking intermediate of the maillard reaction, in uremic patients
10. Increase in three α,β-dicarbonyl compound levels in human uremic plasma: Specific in vivo determination of intermediates in advanced Maillard reaction
11. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure
12. Alterations in non-enzymatic biochemistry in uremia: Origin and significance of 'carbonyl stress' in long-term uremic complications
13. Advanced oxidation protein products as a novel marker of oxidative stress in uremia
14. Protein oxidation in hemodialysis and kidney transplantation
15. Detection of oxidant in uremic plasma by electron spin resonance spectroscopy
16. Metal catalyzed oxidation of proteins. Physiological consequences
17. ε-(carboxymethyl) lysine in aortas of hemodialysis patients
18. Advanced glycation and development of diabetic complications: Unifying the involvement of glucose, methylglyoxal and oxidative stress
19. Erythrocyte redox state in uremic anemia: Effects of hemodialysis and relevance of glutathione metabolism
20. Effects of glycerol-induced acute renal failure on tissue glutathione and glutathione-dependent enzymes in the rat
21. Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia
22. β2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis
23. Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis
24. 2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) inhibits the neointima proliferation of rat carotid artery following balloon injury: Role of glycoxidation and lipoxidation reactions in vascular tissue damage
25. Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: Role in the pathogenesis of peritoneal membrane dysfunction in peritoneal dialysis
26. Advanced glycation and lipoxidation of the peritoneal membrane in peritoneal dialysis: Respective role of serum and peritoneal dialysis fluid reactive carbonyl compounds
27. Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis
28. Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor and interleukin 1
29. Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted with devitalized bone particles
30. Advanced glycation end products increase retinal vascular endothelial growth factor expression
31. c-src
32. 4-Hydroxynonenal triggers an epidermal growth factor receptor-linked signal pathway for growth inhibition
33. 4-Hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death
34. Mechanism of the inhibitory effect of 2 isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) on AGE and ALE formation